Applied DNA Sciences Q3 EPS $0.47 Up From $(4.80) YoY, Sales $797.52K Down From $2.92M YoY
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences (NASDAQ:APDN) reported Q3 earnings of $0.47 per share, a significant improvement from a loss of $(4.80) per share YoY. However, sales decreased by 72.66% to $797.52K from $2.92M YoY.
August 08, 2024 | 10:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences reported a significant improvement in Q3 EPS to $0.47 from a loss of $(4.80) YoY, but experienced a 72.66% decline in sales to $797.52K from $2.92M.
The significant improvement in EPS is a positive indicator for investors, suggesting better profitability. However, the sharp decline in sales may raise concerns about the company's revenue generation capabilities. Overall, the positive EPS is likely to have a more immediate positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100